Vorasidenib-VORANIGO tablet market reference price and drug purchasing channels

Vorasidenib (trade name VORANIGO) is currently not available in the country. Therefore, domestic patients cannot obtain the drug through formal channels for the time being, and it is not included in medical insurance. There is no reference for the domestic price. The drug is mainly used to treat specific types of IDH1/2 mutation-related brain gliomas, providing patients with new targeted treatment options.

In overseas markets, the US version of the original voroxiranib tablets is 40mg*30 tablets. Each box is priced at approximately 38 RMB. The price is relatively high and is mainly targeted at patients undergoing clinical trials or with specific indications. Because it is an innovative targeted drug, drug research and development costs and patent protection are the main reasons for its high price. Currently, there is no domestic agent channel for direct purchase.

In addition to original drugs, generic drugs have also been launched in overseas markets. For example, Voxanib tablets of the same specification produced by Lucius Pharmaceuticals in Laos are priced at more than 7,000 yuan per box. The ingredients of the drug are basically the same as those of the original research, but the price is more affordable. This provides overseas patients with an affordable alternative, but they need to pay attention to the authenticity of the medicine, storage and transportation conditions, and legal compliance when purchasing.

Generally speaking, voxanib is not yet on the market in China, and the channels for purchasing the drug are limited. If patients consider using it, they need to obtain it through overseas clinical trials, imported drug approval, or regular overseas hospital prescriptions. Before use, a doctor should evaluate the mutation status and indications of IDH1/2. At the same time, attention should be paid to the reliability of the drug source, transportation and storage conditions to ensure the safety and efficacy of the treatment.

Reference materials:https://www.drugs.com/